Source: SEC

ReAlta received $25M in Equity Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

CEO

David Marek

CEO Approval Rating

90/100

ReAlta Life Sciences is an early-stage biopharmaceutical company that develops inflammatory mechanisms for treating unmet medical need.